XML 26 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Net Income/(Loss) per Common Share
12 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Net Income/(Loss) per Common Share Net Income/(Loss) per Common Share
Basic net income/(loss) per common share is computed by dividing net income/(loss) by the weighted average number of common shares outstanding during each period. Diluted net income/(loss) per common share is computed by dividing net income/(loss) by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes options and both restricted and performance stock units, is computed using the treasury stock method. With regard to the performance stock units, we assume that the associated performance targets will be met at the target level of performance for purposes of calculating diluted net income per common share until such time that it is probable that the performance target will not be met.
The reconciliations of the denominators used to calculate basic net income/(loss) per common share and diluted net income/(loss) per common share for fiscal 2023, 2022, and 2021, respectively, is as follows:
Year Ended March 31, 2023Year Ended March 31, 2022Year Ended March 31, 2021
Basic net income/(loss) per common share
Net income/(loss) $33,666 $20,092 $877 
Weighted-average common shares outstanding33,468,632 33,308,045 33,134,592 
Basic net income/(loss) per common share$1.01 $0.60 $0.03 
Year Ended March 31, 2023Year Ended March 31, 2022Year Ended March 31, 2021
Diluted net income/(loss) per common share  
Net income/(loss)$33,666 $20,092 $877 
Weighted-average common shares outstanding33,468,632 33,308,045 33,134,592 
Common share equivalents:
Stock options issued7,512 2,231 27,306 
Restricted and performance stock units issued269,792 204,285 179,056 
Weighted average shares outstanding – dilutive 33,745,936 33,514,561 33,340,954 
Diluted net income/(loss) per common share $1.00 $0.60 $0.03 
For the year ended March 31, 2023, 2022, and 2021, 53,911, 110,923 and 85,322 equity awards, respectively, were not included in the calculation of diluted net income/(loss) per common share since they would have had an anti-dilutive effect.